Description
FOXO4-DRI 10 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product.
Research-grade synthetic peptide supplied as a 10 mg sealed vial for lawful laboratory research in the UK. Not a food, supplement or medical device on this page. Not for diagnostic or therapeutic use. Must not be administered to people or animals.
Identification
| Product name | FOXO4-DRI |
| Also listed as | FOXO4 D-retro-inverso peptide |
| Supplier | Opti-Gen Peptides |
| Contents | 10 mg per vial |
| Class | Synthetic D-retro-inverso FOXO4-derived peptide |
| Sequence (commonly cited) | D-retro-inverso form of a FOXO4-p53 interaction region (exact sequence on COA) |
| CAS (commonly cited) | 1798150-59-4 |
| Intended use | Laboratory / in-vitro research only |
Not a licensed senolytic. Not a p53 medicine.
Quality / storage
Only the lot COA applies. Store as a laboratory chemical under institutional SOP. No preparation or application instructions on this page.
Published research context (not product claims)
FOXO4-DRI is a D-retro-inverso peptide designed to disrupt the FOXO4–p53 interaction. Literature associated with Baar, de Keizer and colleagues describes it in cell and animal assay models of senescent-cell pathways.
Those papers are experimental. They are not senolytic, anti-ageing or disease claims for this vial.
There is no MHRA marketing authorisation for this listing.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.